MCCP
GILD icon

Mission Creek Capital Partners’s Gilead Sciences GILD Stock Holding History

Mission Creek Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Sell
1,762
-70
-4% -$9.8K 0.05% 201
2025
Q4 		$225K Sell
1,832
-54
-3% -$6.56K 0.05% 198
2025
Q3 		$209K Hold
1,886
– – 0.04% 197
2025
Q2 		$209K Hold
1,886
– – 0.05% 192
2025
Q1 		$211K Sell
1,886
-1,159
-38% -$120K 0.05% 191
2024
Q4 		$281K Hold
3,045
– – 0.06% 201
2024
Q3 		$255K Sell
3,045
-267
-8% -$20.4K 0.06% 202
2024
Q2 		$227K Sell
3,312
-3,311
-50% -$221K 0.06% 194
2024
Q1 		$485K Sell
6,623
-5,659
-46% -$435K 0.13% 158
2023
Q4 		$995K Sell
12,282
-1,433
-10% -$112K 0.26% 110
2023
Q3 		$1.03M Sell
13,715
-240
-2% -$18.5K 0.35% 98
2023
Q2 		$1.08M Sell
13,955
-1,201
-8% -$95.8K 0.35% 97
2023
Q1 		$1.26M Sell
15,156
-53
-0.3% -$4.39K 0.43% 85
2022
Q4 		$1.31M Sell
15,209
-272
-2% -$21.5K 0.47% 77
2022
Q3 		$955K Sell
15,481
-175
-1% -$11K 0.36% 91
2022
Q2 		$968K Sell
15,656
-50
-0.3% -$3.1K 0.32% 102
2022
Q1 		$934K Sell
15,706
-1,001
-6% -$64K 0.25% 119
2021
Q4 		$1.21M Sell
16,707
-1,566
-9% -$108K 0.24% 115
2021
Q3 		$1.28M Sell
18,273
-470
-3% -$33K 0.24% 110
2021
Q2 		$1.29M Sell
18,743
-683
-4% -$45.6K 0.21% 97
2021
Q1 		$1.26M Sell
19,426
-263
-1% -$17K 0.19% 93
2020
Q4 		$1.15M Sell
19,689
-102
-0.5% -$6.16K 0.35% 87
2020
Q3 		$1.25M Buy
19,791
+11,858
+149% +$822K 0.49% 62
2020
Q2 		$610K Sell
7,933
-25
-0.3% -$1.92K 0.32% 85
2020
Q1 		$595K Sell
7,958
-70
-0.9% -$4.84K 0.32% 76
2019
Q4 		$522K Buy
+8,028
New +$523K 0.24% 109

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mission Creek Capital Partners's GILD Position: Q1 2026 in Review

Mission Creek Capital Partners reduced its Gilead Sciences (GILD) stake by 3.8% in Q1 2026, selling an estimated $9.8K and leaving 1,762 shares worth $246K. The position accounts for 0.05% of the portfolio, ranked #201.

Mission Creek Capital Partners first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.31M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mission Creek Capital Partners held 1,762 shares of Gilead Sciences worth $246K as of Q1 2026.
  • Mission Creek Capital Partners sold 70 Gilead Sciences shares in Q1 2026, an estimated $9.8K.
  • Gilead Sciences made up 0.05% of Mission Creek Capital Partners's portfolio in Q1 2026, its #201 holding.
  • Mission Creek Capital Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • Mission Creek Capital Partners's Gilead Sciences position peaked at $1.31M in Q4 2022.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mission Creek Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.